TY - JOUR
T1 - No impact of central venous insertion site on oncology patients' quality of life and psychological distress. A randomized three-arm trial
AU - Biffi, Roberto
AU - Orsi, Franco
AU - Pozzi, Simonetta
AU - Maldifassi, Andrea
AU - Radice, Davide
AU - Rotmensz, Nicole
AU - Zampino, Maria Giulia
AU - Fazio, Nicola
AU - Peruzzotti, Giulia
AU - Didier, Florence
PY - 2011/10
Y1 - 2011/10
N2 - Purpose: Though totally implantable access ports (TIAP) are extensively used, information from randomized trials about the impact of insertion site on patient's quality of life (QoL) and psychological distress is unavailable. Patients and methods: Four hundred and three patients eligible for receiving intravenous chemotherapy for solid tumours were randomly assigned to implantation of a single type of TIAP, either through a percutaneous landmark access to the internal jugular or an ultrasound-guided access to the subclavian or a surgical cut-down access through the cephalic vein at the deltoid-pectoralis groove. Patients' QoL and psychological distress were investigated at regular intervals by means of EORTC QLQ-C30 and HADS (Hospital Anxiety and Depression Scale) questionnaires, using univariate and multivariate repeated measure linear mixed models. A post hoc analysis investigated the impact of type of administered chemotherapy (adjuvant vs palliative). Results: Three hundred and eighty-four patients (95.2%) were evaluable, 126 with the internal jugular, 132 with the subclavian and 126 with the cephalic vein access. The median follow-up was 361 days (range, 0-1,087). Mean score changes for the items of the EORTC QLQ-C30 scales were significantly associated with type of administered chemotherapy only (P
AB - Purpose: Though totally implantable access ports (TIAP) are extensively used, information from randomized trials about the impact of insertion site on patient's quality of life (QoL) and psychological distress is unavailable. Patients and methods: Four hundred and three patients eligible for receiving intravenous chemotherapy for solid tumours were randomly assigned to implantation of a single type of TIAP, either through a percutaneous landmark access to the internal jugular or an ultrasound-guided access to the subclavian or a surgical cut-down access through the cephalic vein at the deltoid-pectoralis groove. Patients' QoL and psychological distress were investigated at regular intervals by means of EORTC QLQ-C30 and HADS (Hospital Anxiety and Depression Scale) questionnaires, using univariate and multivariate repeated measure linear mixed models. A post hoc analysis investigated the impact of type of administered chemotherapy (adjuvant vs palliative). Results: Three hundred and eighty-four patients (95.2%) were evaluable, 126 with the internal jugular, 132 with the subclavian and 126 with the cephalic vein access. The median follow-up was 361 days (range, 0-1,087). Mean score changes for the items of the EORTC QLQ-C30 scales were significantly associated with type of administered chemotherapy only (P
KW - Chemotherapy
KW - HADS
KW - QoL
KW - TIAP implantation site
UR - http://www.scopus.com/inward/record.url?scp=80052503468&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=80052503468&partnerID=8YFLogxK
U2 - 10.1007/s00520-010-0984-9
DO - 10.1007/s00520-010-0984-9
M3 - Article
C2 - 20803038
AN - SCOPUS:80052503468
VL - 19
SP - 1573
EP - 1580
JO - Supportive Care in Cancer
JF - Supportive Care in Cancer
SN - 0941-4355
IS - 10
ER -